Stockholm Medical Cannabis Conference

Exploring Autistic Spectrum Disorder through the lens of ECS dysfunction

Explore the compelling links between the Endocannabinoid System (ECS) and Autism Spectrum Disorders (ASD). This in-depth review delves into genetic and chemically-induced in vivo models, ECS biomarkers in ASD, and the latest clinical research on ECS-targeted interventions. Understand the ECS’s role as a potential therapeutic target and its broader implications for ASD pathology and treatment.

Beyond the High: Unraveling Non-GPCR Targets in the eCBome

Delve into the lesser-known facets of the endocannabinoid system (eCBome), focusing on non-GPCR targets like FAAH, MAGL, DAGL, NAPE-PLD, TRP channels, and PPARs. Discover their critical roles in human physiology and their potential for therapeutic intervention in neuropsychiatric, metabolic, and neurological disorders.